Overview
ClinChoice is a global contract research organization (CRO) that provides outsourced clinical development services across the full lifecycle for pharmaceutical, biotechnology, medical device, and consumer health customers. It delivers services such as clinical operations, project management, biostatistics, data management, regulatory affairs, medical affairs, and pharmacovigilance to support trials from early development through post-approval. The company differentiates itself with a large, global workforce—over 4,000 professionals in more than 30 countries—and growth through mergers and acquisitions, enabling multinational trial execution. Its goal is to help clients accelerate approvals and navigate complex regulatory environments by offering flexible project-based and FSP engagement models for end-to-end development and lifecycle support.
Work here?Claim your company
Simplify's take
What believers are saying
- Monash University partnered with ClinChoice on March 23, 2026 for early-phase trials.
- Revelio Labs reported 2,339 employees in March 2026 and 133 active 2026 postings.
- Legend Capital's 2022 $150 million round still funds expansion and acquisition capacity.
What critics are saying
- Revelio Labs shows active postings fell 27.8% in 2026, signaling weaker demand.
- ClinChoice's workforce slipped from 2,348 in 2023 to 2,339 in 2026.
- A failed integration of CROMSOURCE, CSI, and Medidata systems would break delivery quality.
What makes ClinChoice unique
- ClinChoice spans 30+ countries, enabling multinational trials across Asia, Europe, and North America.
- Its 2023 CROMSOURCE and 2024 CSI acquisitions deepened full-service and Southeast Asia reach.
- The 2024 Medidata extension adds Clinical Data Studio to its data-management stack.
Help us improve and share your feedback! Did you find this helpful?